CVS Health gains, Under Armour slips following Q1 reports Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- BioLineRx (BLRX) up 59% after announcing an analysis of data from the GENESIS Phase 3 trial evaluating Motixafortide in combination with granulocyte colony stimulating factor found found highly statistically significant evidence across all primary and secondary endpoints favoring Motixafortide in addition to G-CSF, as compared to placebo plus G-CSF
- 51job (JOBS) up 13% after announcing that its board has received an updated preliminary non-binding proposal letter from DCP Services, Ocean Link and Rick Yan, the CEO of the company, with respect to the proposed "going-private" transaction wherein the consortium proposes to acquire all of the outstanding common shares of the company for $79.05 in cash per common share
UP AFTER EARNINGS -
- CVS Health (CVS) up 2%
- Pfizer (PFE) up 1%
- Catalent (CTLT) up 1%
- Cummins (CMI) up 1%
- Warner Music (WMG) up 2%
DOWN AFTER EARNINGS -
- Under Armour (UAA) down 2%
- R1 RCM (RCM) down 6%
- XPO Logistics (XPO) down 2%
- Mosaic (MOS) down 7%
- iRobot (IRBT) down 11%
LOWER -
- SmileDirectClub (SDC) down 9% after disclosing a systems outage that was caused by a cybersecurity incident on April 14
Symbols:
BLRX JOBS CVS PFE UAA UA CTLT WMG CMI RCM XPO MOS IRBT SDC Keywords: Fly Intel, Wall Street, Top Stories, Stocks